Pharmacokinetic interaction of aztreonam with other antibiotics

Journal of Clinical Pharmacology
W A CreaseyA Sugerman

Abstract

The pharmacokinetic interaction of the monobactam antibiotic aztreonam with cephradine, clindamycin, gentamicin, metronidazole, and nafcillin was investigated in five separate studies in 48 healthy male volunteers. All drugs were administered by 30-minute intravenous infusions in single-dose, three-way balanced cross-over studies. Drug levels were measured in serum, protein-free filtrate of serum, and urine. Small changes of no clinical significance were seen when aztreonam was given simultaneously with another antibiotic as compared with each drug alone. Maximum serum concentrations of aztreonam were reduced by 12.6 and 9.8 per cent when it was given with gentamicin and metronidazole, respectively. The percentage of serum aztreonam bound to protein fell by a maximum of 5.0 per cent when the monobactam was given in conjunction with nafcillin and rose by 5.1 per cent when accompanied by cephradine. Twenty-four-hour cumulative urinary excretion of aztreonam and clindamycin rose by 5.2 and 10.9 per cent, respectively, when they were administered simultaneously.

References

Apr 1, 1977·Scottish Medical Journal·A T Willis
Aug 1, 1976·Annals of Internal Medicine·J H Hull, F A Sarubbi
Oct 1, 1976·Clinical Pharmacology and Therapeutics·M RudnickI Singer
May 1, 1973·Journal of Clinical Pharmacology·R M DeHaanW D Vandenbosch
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·E A SwabbD N McKinstry
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·R B SykesJ S Wells
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·E A SwabbA A Sugerman
Jun 1, 1982·Antimicrobial Agents and Chemotherapy·E A SwabbM Frantz

❮ Previous
Next ❯

Citations

Jan 1, 1985·Pharmacology & Therapeutics·R B SykesE A Swabb
Dec 1, 1989·Transplant International : Official Journal of the European Society for Organ Transplantation·R C RietbroekR A Koene
Sep 25, 2017·British Journal of Clinical Pharmacology·Rachel S HaywardJonathan D C Ross
Jul 1, 1986·Pharmacotherapy·S J Childs, G P Bodey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.